A NOVEL observational longiTudinal studY on patients with asthma and/or COPD to describe patient characteristics, treatment patterns and the burden of illness over time and to identify phenotypes and endotypes.
12 Years - 130 Years
Endpoint Classification: -
Intervention Model: -
Primary Purpose: -
Verified 01 May 2023 by AstraZeneca
No locations available
|Chronic airways disease|
Patients with suspected or primary diagnosis of asthma or COPD
Procedure/Surgery: Blood draw
Procedure/Surgery: Lung function measurements
FEV1, FVC, PEF, FEF25-75%, IC, calculated FEV1/FVC ratio and calculated FEV1 % predicted
Procedure/Surgery: Fractional Exhaled Nitric Oxide (FENO)
Measures level of exhaled nitric oxide.